Gene therapy progress and prospects: Novel gene therapy approaches for AIDS
Open Access
- 10 February 2005
- journal article
- review article
- Published by Springer Nature in Gene Therapy
- Vol. 12 (6) , 467-476
- https://doi.org/10.1038/sj.gt.3302488
Abstract
Acquired immunodeficiency syndrome (AIDS), caused by human immunodeficiency virus (HIV), kills millions worldwide every year. Vaccines against HIV still seem a distant promise. Pharmaceutical treatments exist, but these are not always effective, and there is increasing prevalence of viral strains with multidrug resistance. Highly active antiretroviral therapy (HAART) consists of inhibitors of viral enzymes (reverse transcriptase (RT) and protease). Gene therapy, first introduced as intracellular immunization, may offer hopes for new treatments to be used alone, or in conjunction with, conventional small molecule drugs. Gene therapy approaches against HIV-1, including suicide genes, RNA-based technology, dominant negative viral proteins, intracellular antibodies, intrakines, and peptides, are the subject of this review.Keywords
This publication has 92 references indexed in Scilit:
- Heat-shock protein 70 exerts opposing effects on Vpr-dependent and Vpr-independent HIV-1 replication in macrophagesBlood, 2004
- Analysis of the Interactions Between HIV-1 and the Cellular Prion Protein in a Human Cell LineJournal of Molecular Biology, 2004
- Attenuation of HIV-1 Replication in Primary Human Cells with a Designed Zinc Finger Transcription FactorPublished by Elsevier ,2004
- The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeysNature, 2004
- CAF-Mediated Human Immunodeficiency Virus (HIV) Type 1 Transcriptional Inhibition Is Distinct from α-Defensin-1 HIV InhibitionJournal of Virology, 2003
- Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcriptsNature, 2003
- Role of ESCRT-I in Retroviral BuddingJournal of Virology, 2003
- Cloned zebrafish by nuclear transfer from long-term-cultured cellsNature Biotechnology, 2002
- Reduced Cell Surface Expression of CCR5 in CCR5Δ32 Heterozygotes Is Mediated by Gene Dosage, Rather Than by Receptor SequestrationPublished by Elsevier ,2002
- Resistance Is FutileImmunity, 2001